Current approved therapeutic strategies for IPF and LC treatment.

$ 21.00

5
(179)
In stock
Description

Inhaled nano-based therapeutics for pulmonary fibrosis: recent

Small-molecule-mediated OGG1 inhibition attenuates pulmonary

Full article: New treatment directions for IPF: current status of

Massimo DOMINICI, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults

Beatrice ARAMINI, MD PhD

IJMS, Free Full-Text

A comprehensive comparison of the safety and efficacy of drugs in

IJMS, Free Full-Text

Georgina COLÓ, PhD, PhD, Biología del Cáncer

Beyond TGFβ1 - novel treatment strategies targeting lung fibrosis

The oncogenic landscape of the idiopathic pulmonary fibrosis: a